Biomedicines, Free Full-Text
Por um escritor misterioso
Descrição
Alpha-synuclein’s role in diseases termed “synucleinopathies”, including Parkinson’s disease, has been well-documented. However, after over 25 years of research, we still do not fully understand the alpha-synuclein protein and its role in disease. In vitro cellular models are some of the most powerful tools that researchers have at their disposal to understand protein function. Advantages include good control over experimental conditions, the possibility for high throughput, and fewer ethical issues when compared to animal models or the attainment of human samples. On the flip side, their major disadvantages are their questionable relevance and lack of a “whole-brain” environment when it comes to modeling human diseases, such as is the case of neurodegenerative disorders. Although now, with the advent of pluripotent stem cells and the ability to create minibrains in a dish, this is changing. With this review, we aim to wade through the recent alpha-synuclein literature to discuss how different cell culture setups (immortalized cell lines, primary neurons, human induced pluripotent stem cells (hiPSCs), blood–brain barrier models, and brain organoids) can help us understand aggregation pathology in Parkinson’s and other synucleinopathies.
NMR in Biomedicine - Wiley Online Library
Archives Biomedicine
Biomedicines, Free Full-Text
How Nanophotonic Label-Free Biosensors Can Contribute to Rapid and
Gut microbiota and its metabolites in depression: from
Nanobodies as a powerful platform for biomedicine: Trends in
Decoding the Patterns of Self and Nonself by the Innate Immune
Artificial Intelligence in Cardiology
The Ageless Generation: How Advances in Biomedicine Will Transform
NMR in Biomedicine - Wiley Online Library
Frontiers Metabolic Disruption by Naturally Occurring Mycotoxins
Foca Free Download 3.2 - Colaboratory
Caloric restriction in humans reveals immunometabolic regulators
Live Cd Pt Br Get File - Colaboratory